Options traders are taking a defensive stance as the quarter closes. Bears are piling into pharma and EV names, while upcoming earnings from MU and NKE draw concentrated activity.
Concentrix is the clearest signal. The stock carries a short score of 65 and has fallen 39% year to date. Options flow heading into its next print is skewed defensively. That combination of heavy short interest and put-heavy positioning makes it one to watch.
NVIDIA sits in a different position. A director disclosed a $411 million share sale this week. The stock is up 23% year to date, with a 5.4 trillion market cap. Despite the insider exit, the ORTEX options score remains positive, with negative bets drawing the most dollar volume in the semiconductor space.
Micron Technology reports Q4 results this week. Its ORTEX stock score stands at 96.85, near the top of all US names. Analyst upside potential sits at 44%. The stock has surged 269% year to date. Options volume tied to the print is heavy, with negative bets among the largest in the sector by dollar value. Taiwan's August export orders hit a record $103 billion, up sharply year on year. That macro backdrop adds weight to expectations around memory chip demand.
Nike heads into its quarterly print down 43% year to date. The short score is 50.6 and days to cover stand at 4.3. Both figures point to a stock where bears remain present. Options activity ahead of results carries a defensive tone.
Lucid Group and Robinhood round out the names seeing bearish options flow. Robinhood drew attention after the Treasury confirmed auto-enrollment plans for millions of children in Trump Accounts. That policy shift could reorder retail brokerage flows, though the options market has so far leaned cautious on the stock.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
